102 Upon DNA recognition, cGAS accelerates the synthesis of the nucleotide second messenger 2'3-cyclic GMPAMP (cGAMP), which directly interacts with and activates the receptor protein stimulator of interferon genes (STING)
However, as detailed above, cells that exhibit higher levels of mitochondrial activity are less sensitive to 5FU treatment, and those with compromised mitochondrial function are more sensitive, correlating with intrinsic resistance
This allows your body to adjust, often reducing nausea risk
Furthermore, the time-to-onset and severe outcomes of GLP-1 RAs-induced gastrointestinal AEs were also discussed, which was helpful for clinical practice and drug monitoring to a certain extent
Quick Answer: Back pain is not a recognized direct side effect of GLP-1 receptor agonists according to FDA prescribing information and clinical trial data